Problem
Eating disorder care still has major gaps
Many people live with eating disorders, yet specialist treatment and sustained support still do not reach everyone who needs them.
Care varies by region and clinical capacity. Support between appointments can be limited. Even evidence-based treatment can be difficult to implement widely because the burden on both clinicians and patients is high. These are not isolated issues. They are structural gaps in care.
Limited access
Specialist treatment is unevenly available, and the first step into care can already be a barrier.
Limited continuity
Symptoms shift in everyday life, while support is still concentrated around clinical appointments.
Limited scalability
Even evidence-based care can be difficult to extend more broadly without increasing burden.
Opportunity
Digital therapeutics can change eating disorder care
Digital therapeutics are evidence-based therapeutic interventions delivered through digital technology. They are not general wellness apps. They are designed to function as part of treatment.
In eating disorder care, the moments that matter do not occur only in the clinic. They arise around meals, during distress, and in the ordinary flow of daily life. Because many patients are adolescents or young adults, digitally supported care may offer a practical way to extend treatment beyond the clinic.
Approach
How ViveSpoon approaches the problem
The premise is not that an app should replace established treatment. It is that better outcomes may come from combining routine care with a carefully designed digital intervention. ViveSpoon is developing its work on that hypothesis.
Clinical relationships remain central. The aim is to make support easier to continue between visits while treating therapeutic design, research planning, and implementation as one continuous process.
Access
Making the first point of specialist support more realistic and more reachable.
Continuity
Designing support that helps treatment continue beyond the appointment itself.
Scale with quality
Extending support without compromising clinical quality.
Product
Product in development
Spoon DTx is a software-based medical intervention now in development as a digital therapeutic for eating disorders.
The application is not publicly available at this stage. Rather than describing product features, this website outlines the clinical problem being addressed and the direction of the work.
Founder
Member
Masafumi Kameya is a psychiatrist and researcher at Kanazawa University Hospital, where he has long been involved in the clinical care of eating disorders. He is now applying that clinical experience to the research and development of digital therapeutics.
At ViveSpoon, he leads clinical problem definition, therapeutic design, research planning, and early implementation strategy. Together with collaborators across healthcare, research, product, and business development, ViveSpoon aims to build systems that make evidence-based care easier to continue in real-world practice.
Contact
Contact
We welcome enquiries about research, partnerships, and media. If our work is relevant to you, please get in touch.